Literature DB >> 19425085

Bradykinesia, muscle weakness and reduced muscle power in Parkinson's disease.

Natalie E Allen1, Colleen G Canning, Catherine Sherrington, Victor S C Fung.   

Abstract

Muscle power (force x velocity) could clarify the relationship between weakness and bradykinesia in Parkinson's disease (PD). The aims of this study were to determine if patients with PD were weaker and/or less powerful in their leg extensor muscles than a neurologically normal control group and to determine the relative contributions of force and movement velocity/bradykinesia to muscle power in PD. Forty patients with PD and 40 controls were assessed. Strength in Newtons (N) was measured as the heaviest load the participant could lift. Power in Watts (W) was measured by having the participant perform lifts as fast as possible. The PD group were 172 N weaker (95% CI 28-315) and 124 W less powerful at peak power (95% CI 32-216) than controls. However, velocity at maximal power was only reduced compared with controls when lifting light to medium loads. When lifting heavy loads bradykinesia was no longer apparent in the PD group. These results suggest that reduced muscle power in PD at lighter loads arises from weakness and bradykinesia combined, but at heavier loads arises only from weakness. The absence of bradykinesia in the PD group when lifting heavy loads warrants further investigation. 2009 Movement Disorder Society.

Entities:  

Mesh:

Year:  2009        PMID: 19425085     DOI: 10.1002/mds.22609

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Simple change in initial standing position enhances the initiation of gait.

Authors:  Elan Dalton; Mark Bishop; Mark D Tillman; Chris J Hass
Journal:  Med Sci Sports Exerc       Date:  2011-12       Impact factor: 5.411

2.  Exercise and medication effects on persons with Parkinson disease across the domains of disability: a randomized clinical trial.

Authors:  Leland E Dibble; K Bo Foreman; Odessa Addison; Robin L Marcus; Paul C LaStayo
Journal:  J Neurol Phys Ther       Date:  2015-04       Impact factor: 3.649

3.  Is Pallido-Pyramidal Syndrome Still a Useful Concept? No.

Authors:  Hugo Morales-Briceño; Victor S C Fung
Journal:  Mov Disord Clin Pract       Date:  2019-10-14

Review 4.  The Phenomenology of Parkinson's Disease.

Authors:  Christopher W Hess; Mark Hallett
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

Review 5.  Long-term effects of exercise and physical therapy in people with Parkinson disease.

Authors:  Margaret K Mak; Irene S Wong-Yu; Xia Shen; Chloe L Chung
Journal:  Nat Rev Neurol       Date:  2017-10-13       Impact factor: 42.937

Review 6.  Evidence for Early and Regular Physical Therapy and Exercise in Parkinson's Disease.

Authors:  Terry D Ellis; Cristina Colón-Semenza; Tamara R DeAngelis; Cathi A Thomas; Marie-Hélène Saint Hilaire; Gammon M Earhart; Leland E Dibble
Journal:  Semin Neurol       Date:  2021-03-19       Impact factor: 3.420

7.  Reliability in one-repetition maximum performance in people with Parkinson's disease.

Authors:  Thomas A Buckley; Christopher J Hass
Journal:  Parkinsons Dis       Date:  2011-10-26

8.  Progressive resistance exercise and Parkinson's disease: a review of potential mechanisms.

Authors:  Fabian J David; Miriam R Rafferty; Julie A Robichaud; Janey Prodoehl; Wendy M Kohrt; David E Vaillancourt; Daniel M Corcos
Journal:  Parkinsons Dis       Date:  2011-11-24

9.  Can therapeutic Thai massage improve upper limb muscle strength in Parkinson's disease? An objective randomized-controlled trial.

Authors:  Yuka Miyahara; Onanong Jitkritsadakul; Jirada Sringean; Nicharee Aungkab; Surasa Khongprasert; Roongroj Bhidayasiri
Journal:  J Tradit Complement Med       Date:  2018-03-01

10.  Influence of perturbation velocity on balance control in Parkinson's disease.

Authors:  Lars B Oude Nijhuis; John H J Allum; Wandana Nanhoe-Mahabier; Bastiaan R Bloem
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.